slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,26 BGN | +1,95% | +1,95% | +9,44% |
29/02 | Sopharma AD rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
2023 | Sopharma AD (BUL:SFA) kondigt een aandeleninkoop aan. | CI |
Vakgebied
Aantal werknemers: 4 721
Verkoop per activiteit
BGN in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Goods
83,1
%
| - | - | 1 558 | 83,1 % | - |
Pharmaceutical Finished Products
16,9
%
| - | - | 317 | 16,9 % | - |
Verkoop per regio
BGN in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Bulgaria
100,0
%
| 1 202 | 72,3 % | 1 874 | 100,0 % | +55,97% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 40 | 01-10-00 | |
Director of Finance/CFO | - | 01-01-02 | |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Ivan Badinski
BRD | Director/Board Member | - | - |
Investor Relations Contact | - | - | |
Maya Taseva
HRO | Human Resources Officer | - | - |
Lora Dicheva
SAM | Sales & Marketing | - | - |
Galina Angelova
LAW | General Counsel | - | - |
S. Katzarova
LAW | General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 40 | 01-10-00 | |
Bisera Lazarova
BRD | Director/Board Member | - | - |
Director/Board Member | 61 | 01-01-00 | |
Director/Board Member | 59 | 12-07-11 | |
Ivan Badinski
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 179 100 063 | 55 260 634 ( 30,85 %) | 14 328 336 ( 8,000 %) | 30,85 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
SOPHARMA TRADING AD 85.00% | 29 136 171 | 85.00% | 91 595 672 $ |
SOPHARMA AD 8.00% | 14 325 017 | 8.00% | 47 148 358 $ |
SOPHARMA PROPERTIES REIT 40.03% | 8 787 132 | 40.03% | 41 796 608 $ |
DOVERIE UNITED HOLDING AD 25.00% | 5 374 600 | 25.00% | 25 094 491 $ |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Medical Distributors
| |
Unipharm AD
Unipharm AD Pharmaceuticals: MajorHealth Technology Unipharm AD engages in the development, manufacture and sale of medicinal products. Its products include solid and liquid dosage forms and concentrates for hemodialysis. The company was founded on March 17, 1994 and is headquartered in Sofia, Bulgaria. |
Pharmaceuticals: Major
|
Medical Specialties
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,44% | 622 mln. | |
-37,88% | 13,99 mld. | |
-33,12% | 10,67 mld. | |
-22,64% | 6,75 mld. | |
+12,54% | 6,29 mld. | |
-11,17% | 5,88 mld. | |
+75,00% | 4,96 mld. | |
-2,92% | 4,54 mld. | |
-9,20% | 3,74 mld. | |
-19,40% | 3,16 mld. |